Related Experiment Videos
Summary
Maternal heroin or methadone use during pregnancy can impact infant growth. Methadone programs may reduce intrauterine growth issues, but postnatal growth disturbances and infections warrant further study in exposed infants.
Area of Science:
- Neonatal health
- Perinatal addiction studies
- Pediatric growth and development
Background:
- Maternal heroin addiction is linked to intrauterine growth retardation (IUGR).
- Methadone maintenance programs may mitigate some adverse effects of maternal addiction.
- Postnatal growth disturbances are observed in infants exposed to both heroin and methadone in utero.
Purpose of the Study:
- To evaluate the incidence of IUGR in infants born to mothers in methadone programs.
- To investigate postnatal growth patterns in infants exposed to heroin and methadone.
- To explore the role of undiagnosed infections in growth disturbances of infants born to addicted mothers.
Main Methods:
- Comparison of growth parameters (birth weight, length, head circumference) in infants exposed to heroin versus methadone.
- Longitudinal assessment of infant linear growth and head circumference during the first year.
- Case reporting of chronic infections in infants of addicted mothers.
Main Results:
- Infants of mothers in methadone programs (≥3 months) showed appropriate birth measurements for gestational age, with minimal IUGR.
- Postnatal growth disturbances occurred in 35% of heroin-exposed and 25% of methadone-exposed infants.
- Several cases of unsuspected chronic infections were identified in infants, suggesting a potential link to growth issues.
Conclusions:
- Methadone maintenance may reduce the risk of intrauterine growth retardation compared to heroin use.
- Postnatal growth deficits and the impact of undiagnosed infections require further investigation in infants exposed to maternal addiction.